Literature DB >> 18952446

Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).

David J Merkler1, Alexander S Asser, Laura E Baumgart, Natalie Carballo, Sarah E Carpenter, Geoffrey H Chew, Casey C Cosner, Jodi Dusi, Lamar C Galloway, Andrew B Lowe, Edward W Lowe, Lawrence King, Robert D Kendig, Paul C Kline, Robert Malka, Kathleen A Merkler, Neil R McIntyre, Mindy Romero, Benjamin J Wilcox, Terence C Owen.   

Abstract

Peptidyl alpha-hydroxylating monooxygenase (PHM) functions in vivo towards the biosynthesis of alpha-amidated peptide hormones in mammals and insects. PHM is a potential target for the development of inhibitors as drugs for the treatment of human disease and as insecticides for the management of insect pests. We show here that relatively simple ground state analogs of the PHM substrate hippuric acid (C(6)H(5)-CO-NH-CH(2)-COOH) inhibit the enzyme with K(i) values as low as 0.5microM. Substitution of sulfur atom(s) into the hippuric acid analog increases the affinity of PHM for the inhibitor. Replacement of the acetylglycine moiety, -CO-NH-CH(2)-COOH with an S-(thioacetyl)thioglycolic acid moiety, -CS-S-CH(2)-COOH, yields compounds with the highest PHM affinity. Both S-(2-phenylthioacetyl)thioglycolate and S-(4-ethylthiobenzoyl)thioglycolic acid inhibit the proliferation of cultured human prostate cancer cells at concentrations >100-fold excess of their respective K(i) values. Comparison of K(i) values between mammalian PHM and insect PHM shows differences in potency suggesting that a PHM-based insecticide with limited human toxicity can be developed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952446      PMCID: PMC2668526          DOI: 10.1016/j.bmc.2008.10.013

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  73 in total

1.  A molluscan peptide alpha-amidating enzyme precursor that generates five distinct enzymes.

Authors:  S Spijker; A B Smit; B A Eipper; A Malik; R E Mains; W P Geraerts
Journal:  FASEB J       Date:  1999-04       Impact factor: 5.191

2.  Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach.

Authors:  Art E Cho; Victor Guallar; Bruce J Berne; Richard Friesner
Journal:  J Comput Chem       Date:  2005-07-15       Impact factor: 3.376

3.  Substrate-mediated electron transfer in peptidylglycine alpha-hydroxylating monooxygenase.

Authors:  S T Prigge; A S Kolhekar; B A Eipper; R E Mains; L M Amzel
Journal:  Nat Struct Biol       Date:  1999-10

Review 4.  The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.

Authors:  F Holsboer
Journal:  J Psychiatr Res       Date:  1999 May-Jun       Impact factor: 4.791

5.  N-acylglycine amidation: implications for the biosynthesis of fatty acid primary amides.

Authors:  B J Wilcox; K J Ritenour-Rodgers; A S Asser; L E Baumgart; M A Baumgart; D L Boger; J L DeBlassio; M A deLong; U Glufke; M E Henz; L King; K A Merkler; J E Patterson; J J Robleski; J C Vederas; D J Merkler
Journal:  Biochemistry       Date:  1999-03-16       Impact factor: 3.162

Review 6.  Treatment options in androgen-independent prostate cancer.

Authors:  P N Lara; F J Meyers
Journal:  Cancer Invest       Date:  1999       Impact factor: 2.176

7.  Thiorphan, tiopronin, and related analogs as substrates and inhibitors of peptidylglycine alpha-amidating monooxygenase (PAM).

Authors:  Neil R McIntyre; Edward W Lowe; Geoffrey H Chew; Terrence C Owen; David J Merkler
Journal:  FEBS Lett       Date:  2005-12-28       Impact factor: 4.124

8.  Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse.

Authors:  Traci A Czyzyk; Yun Ning; Ming-Sing Hsu; Bonnie Peng; Richard E Mains; Betty A Eipper; John E Pintar
Journal:  Dev Biol       Date:  2005-10-12       Impact factor: 3.582

9.  Key peptide processing enzymes are expressed by a variant form of small-cell carcinoma of the lung.

Authors:  W G North; J Du
Journal:  Peptides       Date:  1998       Impact factor: 3.750

Review 10.  New approaches to the therapy of various tumors based on peptide analogues.

Authors:  A V Schally
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

View more
  5 in total

1.  Evidence for substrate preorganization in the peptidylglycine α-amidating monooxygenase reaction describing the contribution of ground state structure to hydrogen tunneling.

Authors:  Neil R McIntyre; Edward W Lowe; Jonathan L Belof; Milena Ivkovic; Jacob Shafer; Brian Space; David J Merkler
Journal:  J Am Chem Soc       Date:  2010-11-02       Impact factor: 15.419

2.  Inactivation of peptidylglycine α-hydroxylating monooxygenase by cinnamic acid analogs.

Authors:  Neil R McIntyre; Edward W Lowe; Matthew R Battistini; James W Leahy; David J Merkler
Journal:  J Enzyme Inhib Med Chem       Date:  2015-05-29       Impact factor: 5.051

Review 3.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

Review 4.  60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C.

Authors:  Dhivya Kumar; Richard E Mains; Betty A Eipper
Journal:  J Mol Endocrinol       Date:  2015-12-14       Impact factor: 5.098

5.  Effects of copper occupancy on the conformational landscape of peptidylglycine α-hydroxylating monooxygenase.

Authors:  Sweta Maheshwari; Chizu Shimokawa; Katarzyna Rudzka; Chelsey D Kline; Betty A Eipper; Richard E Mains; Sandra B Gabelli; Ninian Blackburn; L Mario Amzel
Journal:  Commun Biol       Date:  2018-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.